Diagnostics & Research · Healthcare
CEO, Board Member
2025-01-01–present
Board Member
Aspira Women's Health Inc. (AWHL)Equibles does not estimate personal net worth.
Get an email with a short summary when Aspira Women's Health Inc. publishes a filing, an earnings call transcript or a press release.
Get AWHL alertsJohn Fraser is recorded as CEO at Aspira Women's Health Inc. (AWHL) since June 17, 2026 and Board Member at Aspira Women's Health Inc. (AWHL) since January 1, 2025. The newest filing on record that lists John Fraser as Board Member at Aspira Women's Health Inc. (AWHL) is dated April 11, 2025. Aspira Women's Health Inc. reported in an 8-K filed June 22, 2026 that John Fraser was appointed Interim Chief Executive Officer, effective June 17, 2026. Aspira Women's Health Inc. reported in an 8-K filed April 8, 2025 that John Fraser was appointed director, effective April 6, 2025. Aspira Women's Health Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Aspira Women's Health Inc. includes Michael Buhle (CEO), Nicole Sandford (CEO and CFO), Sandra Milligan (CEO) and 7 others.
“Effective June 17, 2026, the board of directors (the “Board”) of the Company appointed John Fraser, the Company’s current Chairman of the Board, to serve as its Interim Chief Executive Officer while a search of internal and external candidates is conducted.”
“On April 6, 2025, the Board appointed John Fraser and Cynthia Hundorfean as directors of the Company.”
2026-06-17–present
2025-01-01–present
Last confirmed April 11, 2025
Diagnostics & Research · Healthcare
CEO, Board Member
2025-01-01–present